Standard BioTools Inc. Inventory, Finished Goods, Net of Reserves
Standard BioTools Inc. (LAB) had Inventory, Finished Goods, Net of Reserves of $9.93 million as of 2022-12-31, per its 10-K filed 2023-03-14.
Discontinued › Notes › Inventory, Net, Items Net of Reserve Alternative › Inventory, Finished Goods and Work in Process, Net of Reserves
us-gaap:InventoryFinishedGoodsNetOfReserves · last filed 2023-03-14
- 2022-12-31: Inventory, Finished Goods, Net of Reserves $9.93M.
- 2022-09-30: Inventory, Finished Goods, Net of Reserves $9.03M.
- 2022-06-30: Inventory, Finished Goods, Net of Reserves $10.15M.
- 2022-03-31: Inventory, Finished Goods, Net of Reserves $9.66M.
| Period end | Inventory, Finished Goods, Net of Reserves |
|---|---|
| 2022-12-31 | $9.93M 10-K · filed 2023-03-14 |
| 2022-09-30 | $9.03M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $10.15M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $9.66M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $10.61M 10-K · filed 2023-03-14 |
| 2021-09-30 | $12.12M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $13.09M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $10.96M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $10.18M 10-K · filed 2022-03-08 |
| 2020-09-30 | $9.87M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $8.17M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $7.74M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $7.09M 10-K · filed 2021-02-25 |
| 2019-09-30 | $7.17M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $6.69M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $6.05M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $6.36M 10-K · filed 2020-02-27 |
| 2018-09-30 | $6.68M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $6.54M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $6.87M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $6.59M 10-K · filed 2019-03-18 |
| 2017-09-30 | $8.09M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $8.75M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $9.24M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $9.45M 10-K · filed 2018-03-08 |
| 2016-09-30 | $10.38M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $8.28M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $9.25M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $8.65M 10-K · filed 2017-03-03 |
| 2015-09-30 | $8.53M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $9.13M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $8.12M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $7.80M 10-K · filed 2016-02-29 |
| 2014-09-30 | $8.57M 10-Q · filed 2014-11-06 |
| 2014-06-30 | $8.81M 10-Q · filed 2014-08-04 |
| 2014-03-31 | $6.06M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $3.87M 10-K · filed 2015-02-26 |
| 2013-09-30 | $3.68M 10-Q · filed 2013-11-07 |
| 2013-06-30 | $3.25M 10-Q · filed 2013-08-07 |
| 2013-03-31 | $3.35M 10-Q · filed 2013-05-09 |
| 2012-12-31 | $2.95M 10-K · filed 2014-03-12 |
| 2012-09-30 | $3.09M 10-Q · filed 2012-11-09 |
| 2012-06-30 | $2.32M 10-Q · filed 2012-08-14 |
| 2011-12-31 | $2.56M 10-K · filed 2013-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |